Drug profile · INN
levocetirizine dihydrochloride
LEVOCETIRIZINE DIHYDROCHLORIDE
levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — levocetirizine dihydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is levocetirizine dihydrochloride?
levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for levocetirizine dihydrochloride?
LEVOCETIRIZINE DIHYDROCHLORIDE is a marketed brand name for levocetirizine dihydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levocetirizine dihydrochloride?
levocetirizine dihydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.